Antonetti Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Antonetti Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$8.7K	Hold	853	–	–	0.01%	217
2023 Q2	$6.42K	Hold	853	–	–	0.01%	241
2023 Q1	$7.55K	Hold	853	–	–	0.01%	238
2022 Q4	$7.78K	Hold	853	–	–	0.01%	236
2022 Q3	$7K	Hold	853	–	–	0.01%	244
2022 Q2	$6K	Hold	853	–	–	0.01%	258
2022 Q1	$8K	Hold	853	–	–	0.01%	272
2021 Q4	$7K	Sell	853 -2,800	-77%	-$25.3K	0.01%	320
2021 Q3	$36K	Buy	+3,653	New	+$34.2K	0.03%	186
2014 Q3	–	Sell	-135	Closed	-$7K	–	200
2014 Q2	$7K	Sell	135 -533	-80%	-$27.2K	0.01%	167
2014 Q1	$35K	Hold	668	–	–	0.03%	130
2013 Q4	$27K	Hold	668	–	–	0.02%	157
2013 Q3	$25K	Hold	668	–	–	0.03%	195
2013 Q2	$26K	Buy	+668	New	+$26K	0.03%	198

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Antonetti Capital Management's TEVA Position: Q3 2023 in Review

Antonetti Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2023 at 853 shares worth $8.7K. The position accounts for 0.01% of the portfolio, ranked #217.

Antonetti Capital Management first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $36K in Q3 2021. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

Antonetti Capital Management held 853 shares of Teva Pharmaceuticals worth $8.7K as of Q3 2023.
Antonetti Capital Management left its Teva Pharmaceuticals share count unchanged in Q3 2023.
Teva Pharmaceuticals made up 0.01% of Antonetti Capital Management's portfolio in Q3 2023, its #217 holding.
Antonetti Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Antonetti Capital Management's Teva Pharmaceuticals position peaked at $36K in Q3 2021.
435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.